Pitcairn Co
- SEC CIK
- 0000315014
- Latest filing
- Aug 10, 2026
TAK holding history
Takeda Pharmaceutical Co Ltd in every 13F filed by Pitcairn Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TAK overviewAll 13F holders of TAKFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −15,486−100.0% | Sold out | Holders |
| Q3 2025 | 15,486 | $226.7K | <0.1% | −1,893−10.9% | Reduced | Holders |
| Q2 2025 | 17,379 | $268.7K | <0.1% | −3,293−15.9% | Reduced | Holders |
| Q1 2025 | 20,672 | $307.4K | <0.1% | +3,209+18.4% | Added | Holders |
| Q4 2024 | 17,463 | $231.2K | <0.1% | +5,027+40.4% | Added | Holders |
| Q3 2024 | 12,436 | $176.8K | <0.1% | −115−0.9% | Reduced | Holders |
| Q2 2024 | 12,551 | $162.4K | <0.1% | −1,650−11.6% | Reduced | Holders |
| Q1 2024 | 14,201 | $197.3K | <0.1% | +870+6.5% | Added | Holders |
| Q4 2023 | 13,331 | $190.2K | <0.1% | +13,331 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −10,045−100.0% | Sold out | Holders |
| Q2 2023 | 10,045 | $157.8K | <0.1% | +10,045 | New | Holders |